[go: up one dir, main page]

EA200600989A1 - APPLICATION OF GABOXADOL FOR THE TREATMENT OF CEREBELLS - Google Patents

APPLICATION OF GABOXADOL FOR THE TREATMENT OF CEREBELLS

Info

Publication number
EA200600989A1
EA200600989A1 EA200600989A EA200600989A EA200600989A1 EA 200600989 A1 EA200600989 A1 EA 200600989A1 EA 200600989 A EA200600989 A EA 200600989A EA 200600989 A EA200600989 A EA 200600989A EA 200600989 A1 EA200600989 A1 EA 200600989A1
Authority
EA
Eurasian Patent Office
Prior art keywords
gaboxadol
cerebells
treatment
application
treating insomnia
Prior art date
Application number
EA200600989A
Other languages
Russian (ru)
Inventor
Бьярке Эберт
Йонас Лундаль
Original Assignee
Х. Лундбекк А/С
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34684447&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=EA200600989(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Х. Лундбекк А/С filed Critical Х. Лундбекк А/С
Publication of EA200600989A1 publication Critical patent/EA200600989A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A61K31/423—Oxazoles condensed with carbocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicinal Preparation (AREA)

Abstract

Настоящее изобретение касается способа лечения бессонницы у пациента-человека, нуждающегося в этом, путем введения указанному пациенту такого количества габоксадола в день, которое эффективно для лечения бессонницы.The present invention relates to a method for treating insomnia in a human patient in need thereof by administering to said patient an amount of gaboxadol per day that is effective for treating insomnia.

EA200600989A 2003-12-18 2004-12-14 APPLICATION OF GABOXADOL FOR THE TREATMENT OF CEREBELLS EA200600989A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DKPA200301877 2003-12-18
PCT/DK2004/000861 WO2005058313A1 (en) 2003-12-18 2004-12-14 Use of gaboxadol for treating insomnia

Publications (1)

Publication Number Publication Date
EA200600989A1 true EA200600989A1 (en) 2006-10-27

Family

ID=34684447

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200600989A EA200600989A1 (en) 2003-12-18 2004-12-14 APPLICATION OF GABOXADOL FOR THE TREATMENT OF CEREBELLS

Country Status (17)

Country Link
EP (1) EP1720547A1 (en)
JP (1) JP2007515415A (en)
KR (1) KR20060103335A (en)
CN (1) CN1893942A (en)
AR (1) AR047154A1 (en)
AU (1) AU2004298313A1 (en)
BR (1) BRPI0415893A (en)
CA (1) CA2550610A1 (en)
EA (1) EA200600989A1 (en)
IL (1) IL176239A0 (en)
IS (1) IS8390A (en)
MX (1) MXPA06006685A (en)
NO (1) NO20063320L (en)
SG (1) SG133601A1 (en)
TW (1) TW200528098A (en)
WO (1) WO2005058313A1 (en)
ZA (1) ZA200602762B (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0402118D0 (en) 2004-01-30 2004-03-03 Merck Sharp & Dohme Polymorphic forms of a GABAA agonist
EP1906953A4 (en) * 2005-04-29 2009-05-20 Lundbeck & Co As H FORMS OF ACID SALTS AND BASIC SALTS OF GABOXADOL
MX391708B (en) 2015-07-17 2025-03-21 Ovid Therapeutics Inc METHODS FOR TREATING DEVELOPMENTAL DISORDERS WITH GABOXADOL.
WO2019055369A1 (en) * 2017-09-12 2019-03-21 Ovid Therapeutics Inc. Use of gaboxadol in the treatment of narcolepsy
KR20210062662A (en) 2018-09-20 2021-05-31 오비드 테라퓨틱스 인크. Use of Gaboksadol for the treatment of Tourette's syndrome, ticks and stuttering
WO2020131856A1 (en) * 2018-12-17 2020-06-25 Ovid Therapeutics Inc. Use of gaboxadol for the treatment of non-24 hour sleep-wake disorder
AU2020405060A1 (en) 2019-12-18 2022-06-09 Ovid Therapeutics Inc. Gaboxadol for therapeutic treatment of 1p36 deletion syndrome

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19525598C2 (en) * 1995-07-13 1997-09-25 Max Planck Gesellschaft sleeping pills
CZ20033269A3 (en) * 2001-05-21 2004-03-17 H. Lundbeck A/S Granular preparations of gaboxadol

Also Published As

Publication number Publication date
AR047154A1 (en) 2006-01-11
IS8390A (en) 2006-03-30
ZA200602762B (en) 2007-06-27
IL176239A0 (en) 2006-10-05
JP2007515415A (en) 2007-06-14
EP1720547A1 (en) 2006-11-15
MXPA06006685A (en) 2006-08-23
CN1893942A (en) 2007-01-10
BRPI0415893A (en) 2007-01-09
NO20063320L (en) 2006-07-18
KR20060103335A (en) 2006-09-28
WO2005058313A1 (en) 2005-06-30
SG133601A1 (en) 2007-07-30
CA2550610A1 (en) 2005-06-30
TW200528098A (en) 2005-09-01
AU2004298313A1 (en) 2005-06-30

Similar Documents

Publication Publication Date Title
EA201301078A1 (en) NEW THERAPEUTIC APPROACHES IN THE TREATMENT OF SMT AND RELATED DISORDERS
BR0308928A (en) Use of botulinum toxin for the treatment of cardiovascular disease, as well as composition for use in a cardiovascular procedure.
MY151032A (en) Treatment of tnf? related disorders
NO20074999L (en) Method and preparation for the treatment of peripheral vascular diseases
CY1109229T1 (en) USE OF SPOGGOSIN (2-Methoxyadenosine) For Pain Therapy, Specific Subconscious Pain
BR0308813A (en) Treatment of tuberculosis using pleuromutilin derivatives
DE122009000036I2 (en) Use of dapoxetine, a selective serotonin uptake inhibitor, for the treatment of sexual dysfunction
SE0400184D0 (en) New therapeutic use
EA200501310A1 (en) DERIVATIVES OF BENZOLSULFONAMIDES, METHOD FOR THEIR PRODUCTION AND THEIR APPLICATION FOR THE TREATMENT OF PAIN
EA201000630A1 (en) APPLICATION OF BENZO-CONDENSED HETERO-CYCLIC SULFAMIDE DERIVATIVES TO REDUCE LIPPLE LEVELS IN THE BLOOD
EA200700407A1 (en) HINAZOLIN DERIVATIVES AND THEIR USE IN THE TREATMENT OF THROMBOCYTHEMIA
DK1030667T3 (en) Use of mirtazapine in the manufacture of a medicament for the treatment of sleep apnea
DK1610864T3 (en) Electromagnetic stimulation of patients with osteoporosis
EA200600989A1 (en) APPLICATION OF GABOXADOL FOR THE TREATMENT OF CEREBELLS
BR0316132A (en) Method to stimulate hair growth using benzopyran
DE602004024871D1 (en) POLYAMINE COMPOUNDS FOR THE TREATMENT OF CHEMOKIN RECEPTOR-MEDIATED DISEASES
MXPA05013975A (en) Treatment of amyloid- and epileptogenesis-associated diseases.
ATE449607T1 (en) ARSENIC THERAPY FOR THE TREATMENT OF AUTOIMMUNE DISEASES
DE60108775D1 (en) METHOD FOR THE TREATMENT OF STROKE
NO20024545L (en) Procedures for treating congestive heart failure
EA200601853A1 (en) TREATMENT OF DISTURBED RESPIRATORY FUNCTION
TW200509882A (en) Beauty method
DE60310975D1 (en) USE OF EPOTHILONE FOR THE TREATMENT OF HYPERPARATE HYREOIDISM
TW200512183A (en) 2-alkylidene-19-nor-vitamin d derivatives for the treatment of frailty, muscle damage or sarcopenia
DE60313344D1 (en) USE OF 4-PYRIDYLMETHYL-PHTHALAZINE DERIVATIVES FOR THE PRODUCTION OF A MEDICAMENT FOR THE TREATMENT OF MYELODYSPLASTIC SYNDROMES